HLN
Price
$9.46
Change
+$0.13 (+1.39%)
Updated
Oct 22, 03:16 PM (EDT)
Capitalization
41.99B
8 days until earnings call
Intraday Buy/Sell Signals
LIFD
Price
$0.23
Change
+$0.01 (+4.76%)
Updated
Oct 21 closing price
Capitalization
3.34M
Intraday Buy/Sell Signals
Interact to see
Advertisement

HLN vs LIFD

Header iconHLN vs LIFD Comparison
Open Charts HLN vs LIFDBanner chart's image
Haleon
Price$9.46
Change+$0.13 (+1.39%)
Volume$14.01K
Capitalization41.99B
LFTD Partners
Price$0.23
Change+$0.01 (+4.76%)
Volume$950
Capitalization3.34M
HLN vs LIFD Comparison Chart in %
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIFD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLN vs. LIFD commentary
Oct 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a Buy and LIFD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 22, 2025
Stock price -- (HLN: $9.33 vs. LIFD: $0.22)
Brand notoriety: HLN and LIFD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLN: 73% vs. LIFD: 44%
Market capitalization -- HLN: $41.99B vs. LIFD: $3.34M
HLN [@Pharmaceuticals: Generic] is valued at $41.99B. LIFD’s [@Pharmaceuticals: Generic] market capitalization is $3.34M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.74B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 1 FA rating(s) are green whileLIFD’s FA Score has 0 green FA rating(s).

  • HLN’s FA Score: 1 green, 4 red.
  • LIFD’s FA Score: 0 green, 5 red.
According to our system of comparison, both HLN and LIFD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 4 TA indicator(s) are bullish while LIFD’s TA Score has 2 bullish TA indicator(s).

  • HLN’s TA Score: 4 bullish, 6 bearish.
  • LIFD’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, HLN is a better buy in the short-term than LIFD.

Price Growth

HLN (@Pharmaceuticals: Generic) experienced а +1.74% price change this week, while LIFD (@Pharmaceuticals: Generic) price change was -7.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.07%. For the same industry, the average monthly price growth was -0.67%, and the average quarterly price growth was +42.80%.

Reported Earning Dates

HLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-2.07% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($42B) has a higher market cap than LIFD($3.34M). HLN has higher P/E ratio than LIFD: HLN (20.81) vs LIFD (13.93). HLN YTD gains are higher at: -0.482 vs. LIFD (-54.082). HLN has higher annual earnings (EBITDA): 2.71B vs. LIFD (-11.91K). HLN has more cash in the bank: 676M vs. LIFD (2.12M). LIFD has less debt than HLN: LIFD (4.38M) vs HLN (8.45B). HLN has higher revenues than LIFD: HLN (11B) vs LIFD (36.6M).
HLNLIFDHLN / LIFD
Capitalization42B3.34M1,259,370%
EBITDA2.71B-11.91K-22,777,265%
Gain YTD-0.482-54.0821%
P/E Ratio20.8113.93149%
Revenue11B36.6M30,055%
Total Cash676M2.12M31,947%
Total Debt8.45B4.38M192,882%
FUNDAMENTALS RATINGS
LIFD: Fundamental Ratings
LIFD
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLNLIFD
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
54%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIFD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WMG33.440.14
+0.42%
Warner Music Group Corp
TIC12.13-0.14
-1.14%
Acuren Corp
MAPS1.04-0.03
-2.80%
WM Technology
CLRO4.82-0.25
-5.02%
ClearOne Inc
HYMC7.34-1.36
-15.63%
Hycroft Mining Holding Corp

LIFD and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIFD has been loosely correlated with LVZPF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIFD jumps, then LVZPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIFD
1D Price
Change %
LIFD100%
+7.14%
LVZPF - LIFD
34%
Loosely correlated
N/A
CRRTF - LIFD
29%
Poorly correlated
N/A
BFRI - LIFD
6%
Poorly correlated
+0.69%
HLN - LIFD
5%
Poorly correlated
-0.85%
SHPH - LIFD
3%
Poorly correlated
-5.71%
More